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Young (60-80 days) mice o f  the low fl-glucuronidase strain, C3H/HeJ, showed 
no differences in hepatic levels of  glycosaminoglycans (GAGs) when compared 
to the randombred, "normal" Swiss- Webster mice of  the same age. However, by 
12 months of  age hepatic GAG is nearly twice as high in C3H/HeJ mice as in 
Swiss-Webster mice. Studies of  fl-glucuronidase, fl-galactosidase, and N-ace- 
tyl-[I-glucosaminidase in four tissues of  the two types of  mice at the two ages 
revealed that glucuronidase was the only enzyme with lower activity in the 
C3H/HeJ strain. 
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INTRODUCTION 6 
Mucopolysaccharidosis VII, a severe clinical disease, is thought to be due to a 
deficiency of lysosomal/~-glucuronidase (Sly et  al.,  1973). Fibroblasts from 
patients with this disorder have 1-2% residual/~-glucuronidase (Gehler et  al. ,  
1974; Beaudet et  al. ,  1975). It has been known for some time that mice of the 
C3H/HeJ strain have 5-10% the normal (i.e., the level in most strains of mice) 
amount of acid/~-glucuronidase in several organs (Morrow et  al.,  1949). These 
low levels of/%glucuronidase have allowed the use of this strain of mice as a 
model of enzyme therapy (Thorpe et  al.,  1975), but there has been no evidence 
for accumulation of glycosaminoglycans (GAG) in this strain of mice. We 
herein delineate GAG accumulation in the liver of C3H mice. 
MATERIALS AND M E T H O D S  
Mice 
Inbred C3H/HeJ (C3H) mice were obtained from the Jackson Laboratory, 
Bar Harbor,  Maine. Randombred Swiss-Webster (SW) albino mice were 
obtained from Carworth Farms, Gilroy, California. Shavings were used as 
bedding and the mice were kept in a room with controlled lighting (14 hr light, 
10 hr dark). "Young"  mice were 60-80 days old, while "old" mice were 12 
months old. All mice used were females. 
Determination of Glyeosaminoglyeans 
Mice were killed by cervical dislocation and livers were quickly removed and 
frozen on dry ice. They were later thawed and minced, and the minced livers 
were defatted by two 24-hr extractions with 20-50 vol of acetone-ether (1:1) 
and dried at 100 C for 4 hr. The dried livers were ground in a mortar and 
200-500 mg portions of the livers were rehydrated in 10 vol of 0.1 M phosphate 
buffer, pH 7.5, and heated at 100 C for 20 rain. After cooling, 2 vol of 0.25% 
Pronase B (Calbiochem) was added and the tissues were incubated at 57 C. 
After 12-16 hr another 2 vol of 0.25% Pronase B was added and the incuba- 
tion continued for 24 hr. Sufficient 100% w/v trichloroacetic acid was added to 
make the final concentration 5%. Following centrifugation the supernatant 
extract was decanted and the precipitate was reextracted with 2 ml of 5% 
trichloroacetic acid. The GAGs were precipitated from the combined extract 
by addition of 3 vol of ethanol containing 5% potassium acetate. After 
standing overnight at 4 C, the precipitates were collected by centrifugation 
and washed with alcohol-ether (1:1). The precipitates were dissolved in 2.5 ml 
of 0.15 M NaC1 and clarified by centrifugation. One milliliter of 5% cetylpyri- 
dinium chloride was added to 2 ml of the solution of GAGs. After standing at 
37 C for 4 hr, the tubes were centrifuged and the supernatant solution was 
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decanted. One milliliter of 1.25 M MgC12 was placed in each tube and the sides 
of the tube were carefully wetted with this solution. Three volumes of ethanol 
were then added and the tubes were held overnight at 4 C. After centrifuga- 
tion, the tubes were drained and the GAGs were taken up in a small volume of 
0.15 M NaC1. Aliquots were used for assay of uronic acid according to Bitter 
and Muir (1962). 
Determinations of Glycosidases 
Two grams percent homogenates of fresh or fresh-frozen liver, kidney, and 
spleen were prepared in distilled water using a Potter-Elvehjem homogenizer. 
They were then frozen and thawed three times and cleared by centrifugation at 
12,000 g for 30 rain in a Sorval R2 refrigerated centrifuge. The supernatants, 
or sera, were assayed for the lysosomal acid hydrolases (1) fl-galactosidase, (2) 
N-acetyl-fl-glucosaminidase, and (3) fi-glucuronidase with the fluorometric 
4-methylumbelliferyl substrates at 0.5 mM (Sandman et al., 1973). The buffers 
were slightly different with each substrate: (1) 0.1 M, pFI 4.5 sodium acetate 
with 4-methylumbelliferyl-fl-D-galactopyranoside; (2) 0.1 M, pH 4.75 sodium 
acetate with 4-methylumbelliferyl-fi-D-glucuronide; and (3) 0.21 ionic 
strength, pH 4.6 citrate phosphate with 4-methylumbelliferyl-2-acetamido-2- 
deoxy-fi-D-glucopyranoside. Incubations were carried out for 1 hr at 37 C in 
the presence of 1 mg/ml bovine serum albumin for enzyme stabilization. The 
assays were linear during this time. Proteins were determined by the method of 
Lowry. 
RESULTS 
Young C3H mice had lower (but not statistically significant) levels of liver 
GAGs than did control, SW, mice (Table I). However, liver GAGs increased 
slightly with increasing age in SW mice while they increased markedly in C3H 
mice. The nearly twofold greater levels of GAGs in old C3H as compared to 
old SW mice were compared by Student's t test and found to be significant at 
p<0.01.  
We had chosen to study the GAGs in the two strains of mice because of 
Table I. Determination of  GAGs  in Liver of  SW and C3H Mice (Old and Young) 
SW young SW old C3H young C3H old 
#g GAG-uronic  acid/g of  
dry fat-free liver (15) 230+63 a (4) 277_+.56 (12) 178_+47 (11)488+84 
a (Number  of mice examined) mean + SD. 
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the known deficiency of/%glucuronidase in the C3H strain. We measured 
several GAG-degrading enzymes in the experimental and control mice to 
show that/?-glucuronidase levels of Swiss mice were comparable to those in 
Gus  a and Gusb homozygous mice and that other acid hydrolases were also not 
deficient in C3H mice. Studies on /~-glucuronidase, /~-galactosidase, and 
/%glucosaminidase in liver, kidney, spleen, and serum in young and old C3H 
and SW mice revealed marked deficiencies of/?-glucuronidase in C3H liver 
(Table II). The enzyme values showed much greater variability in the SW 
Table II. Lysosomal Hydrolase Activities in Tissues and Serum: SW and C3H (Young and Old) 














85 ± 32 b 92 ± 40 30 ± 1.3 79 ± 20 
(46 125) c (53-139) (29-32) (67-109) 
447+_83 1200±408 178±24 465_+28 
(382 5 6 8 )  (907-1803) (143-197) (434488) 
221±13.4 191±41 1 6 . 2 _ + 1 . 5  30.5±24.5 
(204-235) (145-245) (15-18) (16-67) 
394±162 162±88 151 - + 7 . 5  177±12 
(191-585) (92-276) (146 162) (162 187) 
1176±112 1525±574 1135±44 1758±78 
(1055-1317) (1104-2353) (1075-1180) (1646-1827) 
117_+ 18 54±6.8 39± 14 23+_3 
(98-142) (47-63) (28-58) (20-27) 
236±107 265±199 199_+13 205_+38 
(114-374) (159-565) (188 218) (165 246) 
1697± 112 3195±626 1772_+ 125 1949+ 116 
(1615-1856) (2653-4088) (1629 1902) (1786-2044) 
333±38 290±67 122_+7.1 86+_13 
(297-384) (240-390) (117-133) (73-103) 
nmol/hr/ml serum 
Serum 
/~-Galactosidase 29 ± 12 32 ± 11 14 ± 3.9 19 _ 2.4 
(13.544) (22-48.5) (10.5-19.5) (15.5 21) 
N-Acetyl-/~-glucosaminidase 1427 ± 332 2827 ± 401 728 ± 51 891 ± 212 
(1024-1722) (2450-3334) (686-803) (712-1198) 
/LGlucuronidase 36 +_ 4.0 47 ± 24 4.1 _+ 1.4 5.6 + 1.4 
(30.5+40) (28-81) (3.0.6.0) (4.0-7.5) 
a Six female mice. 
8 Mean ± SD. 
c Range. 
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mice, as is expected for randombred mice. The livers of young C3H mice 
contained 7.3% as much/~-glucuronidase as did young SW livers; at 12 months 
the level was 16% of normal. The deficiency was less severe in kidney (33% of 
SW young, 42% of SW old) and increased with age in spleen (37% of SW 
young, 30% of SW old). Although/%galactosidase was relatively deficient in 
young C3H liver, kidney, and serum, old C3H mice were comparable to old 
SW mice in liver and kidney. Similarly, although N-acetylglucosaminidase in 
C3H liver was 40% of SW levels in both young and old mice, comparable and 
higher levels were found in young and old kidneys, respectively, while compar- 
able levels were found in young spleens. The levels of lysosomal enzymes 
generally increased with age in both strains of mice except for/3-glucuroni- 
dase, which tended to decrease with age in C3H mice. Thus, among the 
enzymes studied, only/%glucuronidase was markedly decreased in C3H mice, 
liver and serum showing the largest decreases. 
DISCUSSION 
The structural gene for/%glucuronidase in mice, Gus, is located near the end of 
chromosome 5, and is known to have three common alleles (Paigen et al., 
1976). Gus a and Gusb determinine electrophoretically distinguishable forms, 
while Gus h, the allele characteristic of the C3H strain, determines a heat-labile 
enzyme which has not been shown to be altered in its other physical and 
chemical properties. Radiopulse-immunoprecipitation studies have shown 
that the rate of synthesis of/~-glucuronidase in the C3H strain is proportional 
to the enzymatic activity, and that the ratio of synthesis to activity is the same 
in C3H as in other strains (Paigen et al., 1976). Thus the lowered activity of 
/?-glucuronidase in C3H mice does not seem to be due to increased in vivo 
lability or to the presence of inhibitors. 
It is a moot point whether or not one could expect external evidence of 
/%glucuronidase deficiency in C3H mice. Human patients with nearly com- 
plete deficiencies have been diagnosed in the first year of life (Sly et al., 1973; 
Beaudet et al., 1975), although the features of another patient (Beaudet et al., 
1975) did not suggest a storage disease until the second decade of life. Smaller 
animals, mice included, have higher fluxes of compounds involved in energy 
metabolism, but few data are available on the rates of synthesis or turnover of 
structural macromolecules such as GAGs. The twofold increase in hepatic 
GAGs in 12-month-old C3H mice is small compared to the hundredfold 
increase found in affected human liver (Brown, 1957). One might expect some 
evidence of storage in the nervous system, but neurological examinations are 
difficult to perform in mice--it took years for users of C3H mice to realize that 
they were blind from about 3 weeks of age because of homozygosity for a 
second mutation, retinal degeneration (Noell, 1958). 
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It is highly likely that the hepatic storage of GAGs in aged C3H mice is 
due to their relative deficiency of/~-glucuronidase. Studies of two other 
lysosomal enzymes did not reveal major deficiencies and did not suggest that a 
general decrease had occurred in lysosomal enzymes, due to complexing with 
undegraded substrate, as might have occurred with accumulation of GAGs 
due to some other cause (Kint, 1974). However, it is possible that some other 
of the about ten enzymes already identified as involved in GAG degradation is 
deficient in C3H mice. A congenic line of mice with the Gus h allele homo- 
zygous on a non-C3H background has been developed (LaVail and Sidman, 
1974), and would clearly resolve the question, but was not available to us at 
this time. 
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